CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025

Award

Buyers

Value

£9,867,000

Classifications

  • Pharmaceutical products

Tags

  • award

Submission Deadline

3 months ago

Published

1 month ago

Description

Project title: NHS National Framework for Transition products commencing 1 February 2025
Offer reference number: CM/TNS/24/5713
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Potential periods of call-offs under the framework agreement:

CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection

Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months)
Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months)
Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete